Cointime

Regulus Therapeutics

company

About

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

  • 51 - 100

Highlights

Total Funding Amount
$10M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Funding Round
Last Funding Money Raised
$10M
Industries
Biotechnology,Genetics,Health Care,Therapeutics
Founded date
Sep 1, 2007
Number Of Employee
51 - 100
Operating Status
Active

Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression.

It was founded in 2007 and is headquartered in Carlsbad, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Regulus Therapeutics has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Oct 28, 2010 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 28, 2010 Funding Round $10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Regulus Therapeutics is funded by 1 investors. Sanofi are the most recent investors.
Investor Name Lead Investor Funding Round
Sanofi — Funding Round
Cointime
Содержание
компания